Is Sotac Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Sotac Pharmaceuticals Ltd (SOTAC.NS) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Sotac Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Sotac Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Sotac Pharmaceuticals Ltd?

Muslim investors may consider investing in Sotac Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Sotac Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Sotac Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Sotac Pharmaceuticals Ltd updated?

The Shariah compliance status of Sotac Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Sotac Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Sotac Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Sotac Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Sotac Pharmaceuticals Ltd SOTAC.NS

₹111.30

Last Updated: May 15, 12:00 AM·NSE

SOTAC.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: January 14, 2026

Report Source: 2026 2nd Quarter Report

Sotac Pharmaceuticals Ltd. Stock Analysis SOTAC.NS

India Health Care Nano Cap Report: Q2, 2026

Sotac Pharmaceuticals Ltd. engages in the developing and manufacturing of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat and currently employs 67 full-time employees. The company went IPO on 2023-04-13. The firm manufactures pharmaceutical products such as tablets, capsules (general & beta-lactum), oral liquid, dry syrup and external preparations. Its services include contract manufacturing, loan license, formulation and development (F&D) and research and development (R&D). Its products portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacids, anti-ulcerants, proton pump inhibitors (PPIs), anti-emetics, cardiac care, anti-hypertensives, analgesics, anti-pyretics, antiinflammatory, anti-bacterial, anti-viral, general antibiotics (IP-Lactams & Non-IP-Lactams), anti-fungal, and cephalosporin products. The company also manufactures nutraceuticals products and food products on contract-manufacturing basis. Its subsidiaries include Sotac Healthcare Private Limited, Sotac Research Private Limited, and Sotac Lifesciences Private Limited.

Key Statistics of Sotac Pharmaceuticals Ltd (SOTAC.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹111.30₹111.30

Today's Open

₹111.30

Volume

1200.00

P/E Ratio (TTM)

14.59

52 Week Range

₹100.00₹152.35

Market Cap

1.23B

Avg. Volume

2640.00

Dividend Yield

Financial Metrics & Statements of Sotac Pharmaceuticals Ltd (SOTAC.NS)

FAQ's for Sotac Pharmaceuticals Ltd (SOTAC.NS)

According to Musaffa’s Shariah screening methodology, Sotac Pharmaceuticals Ltd (SOTAC.NS) is currently classified as HALAL as of January 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.